Wolverine Asset Management LLC trimmed its holdings in shares of Aimei Health Technology Co., Ltd. (NASDAQ:AFJK - Free Report) by 37.6% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 407,799 shares of the company's stock after selling 246,240 shares during the quarter. Wolverine Asset Management LLC owned about 6.66% of Aimei Health Technology worth $4,485,000 at the end of the most recent quarter.
Several other hedge funds have also recently bought and sold shares of AFJK. Harraden Circle Investments LLC acquired a new position in Aimei Health Technology during the fourth quarter worth $1,117,000. Quarry LP acquired a new position in Aimei Health Technology during the fourth quarter worth $1,605,000. Berkley W R Corp acquired a new position in Aimei Health Technology during the fourth quarter worth $4,750,000. Finally, Centiva Capital LP increased its position in Aimei Health Technology by 1.4% during the fourth quarter. Centiva Capital LP now owns 232,693 shares of the company's stock worth $2,460,000 after buying an additional 3,100 shares during the last quarter. 45.58% of the stock is owned by institutional investors and hedge funds.
Aimei Health Technology Trading Up 0.3%
Aimei Health Technology stock traded up $0.03 during mid-day trading on Friday, hitting $11.20. 200 shares of the company's stock were exchanged, compared to its average volume of 1,660. Aimei Health Technology Co., Ltd. has a 1-year low of $10.24 and a 1-year high of $11.30. The stock has a 50 day moving average of $11.16 and a two-hundred day moving average of $11.04.
About Aimei Health Technology
(
Free Report)
Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.
Read More

Before you consider Aimei Health Technology, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aimei Health Technology wasn't on the list.
While Aimei Health Technology currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.